RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
11.42
-0.10 (-0.87%)
At close: Nov 28, 2025, 1:00 PM EST
11.26
-0.16 (-1.40%)
After-hours: Nov 28, 2025, 4:48 PM EST
RxSight Market Cap
RxSight has a market cap or net worth of $469.55 million as of November 28, 2025. Its market cap has decreased by -74.37% in one year.
Market Cap
469.55M
Enterprise Value
253.60M
1-Year Change
-74.37%
Ranking
Category
Stock Price
$11.42
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $469.55M, an increase of 10.66%. That is a compound annual growth rate of 2.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 469.55M | -66.11% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |